Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Double Blind Placebo-controlled Parallel-group Randomized Clinical Study of Efficacy and Safety of Raphamin in the Treatment of Acute Respiratory Viral Infection in Children Aged 12-18 Years Old

NCT04918771 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT04918771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04918771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Double Blind Placebo-controlled Parallel-group Randomized Clinical Study of Efficacy and Safety of Raphamin in the Treatment of Acute Respiratory Viral Infection in Children Aged 12-18 Years Old
Lead sponsor
Materia Medica Holding
Phase
Phase 3
Overall status
Completed
Start date
April 29, 2021
Completion date
July 21, 2023
Enrollment
435 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory viral infection